KA
DBD

Kovack Advisors’s Diebold Nixdorf Incorporated DBD Stock Holding History

Kovack Advisors’s Portfolio DBD Stock Details DBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-24,086
Closed -$28.9K – 659
2023
Q1 		$28.9K Sell
24,086
-1,500
-6% -$3.34K ﹤0.01% 582
2022
Q4 		$36.3K Sell
25,586
-460
-2% -$987 0.01% 533
2022
Q3 		$64K Sell
26,046
-1,700
-6% -$5.67K 0.01% 541
2022
Q2 		$63K Sell
27,746
-3,795
-12% -$14.1K 0.01% 585
2022
Q1 		$212K Sell
31,541
-1,590
-5% -$13.6K 0.02% 635
2021
Q4 		$300K Sell
33,131
-4,102
-11% -$38.1K 0.03% 529
2021
Q3 		$376K Sell
37,233
-25
-0.1% -$274 0.04% 446
2021
Q2 		$478K Sell
37,258
-1,600
-4% -$21.9K 0.05% 367
2021
Q1 		$549K Sell
38,858
-250
-0.6% -$3.44K 0.07% 292
2020
Q4 		$417K Sell
39,108
-4,450
-10% -$40.4K 0.06% 321
2020
Q3 		$333K Sell
43,558
-2,600
-6% -$19.1K 0.06% 307
2020
Q2 		$280K Sell
46,158
-8,405
-15% -$41.5K 0.05% 339
2020
Q1 		$192K Buy
54,563
+26,350
+93% +$223K 0.04% 378
2019
Q4 		$298K Sell
28,213
-1,870
-6% -$16.6K 0.05% 354
2019
Q3 		$337K Buy
30,083
+1,323
+5% +$15.7K 0.07% 308
2019
Q2 		$263K Buy
28,760
+4,935
+21% +$51.5K 0.06% 336
2019
Q1 		$264K Buy
23,825
+100
+0.4% +$699 0.07% 318
2018
Q4 		$59K Sell
23,725
-2,050
-8% -$7.35K 0.02% 390
2018
Q3 		$116K Buy
25,775
+4,050
+19% +$29.5K 0.03% 406
2018
Q2 		$260K Sell
21,725
-202
-0.9% -$2.7K 0.07% 305
2018
Q1 		$338K Sell
21,927
-5,450
-20% -$91K 0.08% 279
2017
Q4 		$448K Sell
27,377
-1,509
-5% -$29.2K 0.11% 212
2017
Q3 		$660K Sell
28,886
-2,660
-8% -$56.7K 0.22% 115
2017
Q2 		$883K Sell
31,546
-3,390
-10% -$93.8K 0.28% 79
2017
Q1 		$1.07M Sell
34,936
-5,350
-13% -$151K 0.42% 48
2016
Q4 		$1.01M Sell
40,286
-4,150
-9% -$97.9K 0.48% 36
2016
Q3 		$1.1M Sell
44,436
-1,200
-3% -$31.9K 0.54% 41
2016
Q2 		$1.13M Buy
45,636
+31,025
+212% +$799K 0.6% 37
2016
Q1 		$422K Buy
14,611
+1,000
+7% +$26.1K 0.26% 106
2015
Q4 		$410K Hold
13,611
– – 0.27% 103
2015
Q3 		$405K Hold
13,611
– – 0.28% 95
2015
Q2 		$476K Hold
13,611
– – 0.34% 70
2015
Q1 		$483K Buy
+13,611
New +$459K 0.41% 59

Other funds holding DBD

Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return
BFIM
Beese Fulmer Investment Management Canton, Ohio $1.56B AUM 26.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Kovack Advisors's DBD Position: Q2 2023 in Review

Kovack Advisors sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 24,086 shares — an estimated $28.9K sold.

Kovack Advisors first reported a position in DBD in Q1 2015 and held it in 33 quarters. The position peaked at $1.13M in Q2 2016. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.

  • Kovack Advisors reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
  • Kovack Advisors sold 24,086 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $28.9K.
  • Kovack Advisors first reported a position in Diebold Nixdorf Incorporated in Q1 2015 and held it in 33 quarters.
  • Kovack Advisors's Diebold Nixdorf Incorporated position peaked at $1.13M in Q2 2016.
  • 7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.

Based on Kovack Advisors's 13F filing for Q2 2023, filed 21 Jul 2023.